Carr Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Carr Financial Group's PFE Position: Q3 2025 in Review
Carr Financial Group sold out of Pfizer (PFE) in Q3 2025, closing a stake of 10,943 shares — an estimated $265K sold.
Carr Financial Group first reported a position in PFE in Q4 2022 and held it in 11 quarters. The position peaked at $655K in Q3 2024. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Carr Financial Group reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Carr Financial Group sold 10,943 Pfizer shares in Q3 2025, an estimated $265K.
- Carr Financial Group first reported a position in Pfizer in Q4 2022 and held it in 11 quarters.
- Carr Financial Group's Pfizer position peaked at $655K in Q3 2024.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Carr Financial Group's 13F filing for Q3 2025, filed 8 Oct 2025.